Expanding HIV Therapy with Nanomedicine

Current antiretroviral therapies have transformed the concept of HIV from a fatal disease to a manageable chronic condition. However, the global burden continues to grow including young children for whom HIV medicines are not adequately available. Management includes daily oral administration of medications in high doses leading to high costs and high non-compliance. Resent research in nanotechnology promises changes in oral medications that will surmount these challenges through improved drug absorption significantly improving administration and reducing the dose and the cost. This would enable consistent treatment for more patients and better formulas for children. Click here to learn more. Read more.